211 related articles for article (PubMed ID: 30744649)
1. Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States.
Yu TC; Nguyen C; Ruiz N; Zhou S; Zhang X; Böing EA; Tan H
BMC Pediatr; 2019 Feb; 19(1):53. PubMed ID: 30744649
[TBL] [Abstract][Full Text] [Related]
2. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study.
Vidavalur R; Devapatla S
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7701-7706. PubMed ID: 34470114
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care.
Fein EH; Friedlander S; Lu Y; Pak Y; Sakai-Bizmark R; Smith LM; Chantry CJ; Chung PJ
Hosp Pediatr; 2019 Feb; 9(2):115-120. PubMed ID: 30606776
[TBL] [Abstract][Full Text] [Related]
4. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
Xu C; Bao Y; He Y; Wu M; Zhu J
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
7. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
8. Hyperbilirubinemia in newborns with gestation ≥35 weeks.
Sankaran K
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Oct; 12(10):761-6. PubMed ID: 20959036
[No Abstract] [Full Text] [Related]
9. Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia.
Rasiah S; Jegathesan T; Campbell DM; Shah PS; Sgro MD
Pediatr Res; 2023 Dec; 94(6):2092-2097. PubMed ID: 37491586
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of universal hyperbilirubinemia screening on newborn health: a systematic review protocol.
Khurshid F; Medves J
JBI Database System Rev Implement Rep; 2018 Feb; 16(2):287-290. PubMed ID: 29419612
[TBL] [Abstract][Full Text] [Related]
11. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey.
Hakan N; Zenciroglu A; Aydin M; Okumus N; Dursun A; Dilli D
J Matern Fetal Neonatal Med; 2015 Sep; 28(13):1537-41. PubMed ID: 25182682
[TBL] [Abstract][Full Text] [Related]
12. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
13. Overview of neonatal hyperbilirubinemia at Nepal Medical College Teaching Hospital.
Rijal P; Bichha RP; Pandit BP; Lama L
Nepal Med Coll J; 2011 Sep; 13(3):205-7. PubMed ID: 22808817
[TBL] [Abstract][Full Text] [Related]
14. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia.
Berkwitt A; Osborn R; Grossman M
Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
17. Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: A hospital-based retrospective study.
Al-Omran A; Al-Abdi S; Al-Salam Z
J Neonatal Perinatal Med; 2017; 10(2):181-189. PubMed ID: 28409762
[TBL] [Abstract][Full Text] [Related]
18. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
19. The use of intensive phototherapy in severe neonatal hyperbilirubinemia.
Abd-Ellatif MA; Abd-Ellatif DA
J Egypt Soc Parasitol; 2012 Aug; 42(2):483-94. PubMed ID: 23214225
[TBL] [Abstract][Full Text] [Related]
20. Hyperbilirubinemia: current guidelines and emerging therapies.
Schwartz HP; Haberman BE; Ruddy RM
Pediatr Emerg Care; 2011 Sep; 27(9):884-9. PubMed ID: 21926893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
